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Abstract 
 
Glucocorticoid (GC) hormones can bind two structurally and functionally related steroid 
receptors: the GC Receptor (GR or Nr3c1) and the mineralocorticoid receptor (MR or Nr3c2), 
which recognize the same DNA response elements and act as ligand-dependent transcription 
factors. While the crucial role of GR for skin homeostasis has been widely characterized, the 
exact role of MR in this tissue deserves further study. We assessed NR3C2 expression in 
developing and adult WT mouse skin and found a transient peak at embryonic day (E)16.5, 
which along with low levels of HSD11B2, the enzyme inactivating GCs, supports a role for GC-
MR complexes in epidermal maturation. Consistent with this observation, MR-/- embryonic skin 
showed alterations in early epidermal differentiation that resolved postnatally. The lack of a 
more severe skin phenotype of MR-/- mice suggests functional compensation by GR in this 
tissue in the perinatal period. 
  
Background 
The importance of hormonal regulation in skin is evidenced by numerous endocrine 
abnormalities with cutaneous manifestations, including disorders of the epidermal barrier and 
hair (1, s1). Hormone action is mediated by nuclear receptor superfamily members, ligand-
activated transcription factors that integrate multiple cellular processes, including the 
glucocorticoid (GC) receptor (GR or Nr3c1) and the mineralocorticoid receptor (MR or Nr3c2) 
(2). Both proteins are structurally and functionally related, and upon GC binding recognize the 
same hormone responsive elements to transcriptionally regulate target genes (3-5). GC access to 
GR and MR is modulated by two enzymes, 11-hydroxy steroid dehydrogenases type I and II 
(HSD11B1/HSD11B2), which mediate interconversion between inactive and active GCs. 
Human and mouse skin can synthesize GCs and key enzymes of steroid synthesis, acting as a 
functional hypothalamo-pituitary-adrenal axis to secure epidermal homeostasis (6, s2, s3). 
While our previous work demonstrated that GR is required for epidermal development and 
homeostasis (7, 8, s4), much less is known regarding MR in this tissue (9). Remarkably, 
transgenic mice with keratinocyte-specific overexpression of either MR or GR (s5, s6) showed 
strong phenotypical similarities at birth including atrophic skin, reduced hair follicle number, 
and impaired epidermal maturation. 
 
Questions addressed 
We have analyzed: i) MR expression during mouse skin development; ii) the consequences of 
MR inactivation in developing mouse skin; and iii) the relative expression of 
HSD11B1/HSD11B2 during this process. 
 
Experimental design 
Animal Experimentation 
MR-/- mice were generated using generalized CRE-mediated recombination by intercrossing 
K5-cre mice (s7) and MRloxP/loxP mice (s8). 
 
Sample processing 
Skin samples were collected from at least three individuals of each genotype and age and 
analyzed as reported (8). Mean value ± SD was calculated and statistical significance assessed 
using the Student’s t-test (8). 
 
Results 
We analyzed the relative expression of Nr3c2 by RT-QPCR in WT embryonic (E)18.5 and adult 
mouse skin in the telogen (8-wk old) and anagen (5-wk old) phases of the hair cycle. Nr3c2 
levels were 17-fold higher in telogen relative to anagen skin, suggesting a role for MR in the 
resting phase of the hair cycle; however, Nr3c2 was most abundant in E18.5 skin, 5-fold higher 
than in telogen adult skin (Fig. 1A). Assessment of Nr3c2 during skin development revealed a 
peak in expression at E16.5 which decreased thereafter (E18.5 and postnatal day 0 (P0); Fig. 
1B). These findings were paralleled by changes in MR protein expression in developing and 
adult skin (Fig. 1C). Nr3c1 levels also peaked in E16.5 skin but unlike Nr3c2 did not decrease 
at later timepoints (Fig. S1). Krt77 and Sprr2d are controls known to be expressed differentially 
during epidermal development (Fig. S1).  
To evaluate the consequences of MR loss-of-function in developing skin, we generated 
MR-/- mice (Fig. 1D) using generalized CRE-mediated recombination in MRloxP/loxP mice (Supp. 
Information; s7, s8). MR-/- mice died perinatally around P10 similar to MRnull/null mice (s9), 
presumably due to renal loss of sodium and water (not shown). Epidermal permeability assays 
in MR+/- and MR-/- E17.5 embryos showed no major changes in the pattern of barrier formation 
among genotypes (Fig. 1E). However, analysis of Hematoxylin/Eosin stained skin sections 
showed statistically significant increases of epidermal thickness in MR-/- relative to MR+/- 
embryos (Fig. 1E, F). Altered differentiation, with a more restricted expression of keratin (K)5 
and abnormal expression patterns of K10 and loricrin (LOR) were also detected in MR-/- 
embryos and quantitated as minor but statistically significant changes of percent positive layers 
(Fig. 1E, G). These alterations resolved spontaneously with age as MR-/- skin had a similar 
appearance as MR+/- or WT littermates at P0 and P4 (Fig. 2 and data not shown). We assessed 
stratum corneum lipids by Nile red staining and quantitated epidermal thickness and loricrin 
staining in postnatal skin samples but found no changes among genotypes (Fig. 2A and S2). 
MR-/- epidermal proliferation was unchanged at P0 but statistically significant increases were 
detected at P4 (Fig. 2B), relative to controls; however, we cannot exclude the possibility that the 
MR-/- postnatal renal defects indirectly affect proliferation in this tissue. 
To understand whether the transient role of MR in epidermal development is due to 
alterations in GC availability, we assessed Hsd11b1 and Hsd11b2 in skin at distinct stages and 
observed pronounced peaks in expression for both genes at E18.5 (Fig. 2C). In adult skin, the 
expression of Hsd11b1 decreased 2-fold and that of Hsd11b2 more than 30-fold relative to 
E18.5. Immunostaining confirmed the restricted expression of HSD11B2 to the upper epidermal 
layers with statistically significant increases at P0 (Fig. 2D and S3A). Importantly, HSD11B2 
epidermal expression was similar in MR+/+ vs MR-/- mice but decreased significantly in GR-/- 
skin (Fig. 2E and S3B). 
The -subunit of the amiloride-sensitive epithelial Na channel (ENaC/Scnn1a), 
necessary for epidermal homeostasis, is a transcriptional target of both MR and GR (s10). We 
assessed whether the absence of MR affected ENaC but found no differences in P0 skin (Fig. 
S4), similar to that reported in colon and kidney of MR-/- newborn mice (s11). The fact that 
Nr3c1 levels are unchanged in MR-/- skin suggests that GR expression is not negatively affected 
by loss of MR (Fig. S4). 
 
Conclusions 
Our findings indicate that MR plays a role in regulating epidermal differentiation at late 
embryonic stages. The transient expression peak of MR at E16.5, coinciding with low levels of 
HSD11B2, argues for a role of GC-MR complexes in epidermal maturation. The fact that 
HSD11B2 was virtually absent in GR-/- skin but normally expressed in MR-/- skin, together with 
its reported induction by dexamethasone in human keratinocytes (s12), suggests this enzyme is 
regulated by GR but not MR, and may represent a mechanism to modulate GC-dependent 
actions locally. The hypothalamo-pituitary-adrenal axis becomes active around E15.5 ensuring 
proper control of circulating GC and aldosterone levels, which are normally high perinatally 
(s13). MR and GR expression peaks shortly afterwards, at E16.5. MR expression decreases at 
later developmental timepoints while that for GR remains constant. This observation together 
with our phenotypic data supports the hypothesis that MR plays a transient role in skin 
development. While GR-/- late embryos featured defective epidermal differentiation with 
virtually absent stratum corneum and impaired barrier function (s4), the skin phenotype of MR-/- 
embryos was relatively milder suggesting functional compensation by GR in the perinatal 
period. 
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Figure Legends 
 
Fig. 1. MR expression in WT developing and adult mouse skin (A-C), and epidermal barrier 
formation and skin architecture in MR-/- mice (D-G). A. RT-QPCR data showing relative Nr3c2 
mRNA levels in WT developing (embryonic E18.5) and telogen and anagen adult mouse skin. 
Asterisks indicate statistically significant differences relative to E18.5. (n= 3 per age; * p-value 
<0.05; *** p-value <0.001). B. Relative Nr3c2 mRNA levels in embryonic (E15.5-E18.5) and 
newborn (P0) mouse skin. Asterisks indicate statistically significant differences relative to 
E15.5 (n= 4 per age; *** p-value <0.001). C. Western blot showing MR protein in developing 
(E16.5, E18.5, P0) and adult mouse skin (8-wk old). Kidney whole cell extracts from MR-/- P0 
or WT adult (K) demonstrate the specificity of the MR antibody. Actin is used as a loading 
control. D. Nr3c2 transcript levels were assessed in MR+/+, MR+/-, and MR-/- P0 skin. Asterisks 
indicate statistically significant differences relative to MR+/+ (n= at least 3 per genotype; ** p-
value <0.01; *** p-value <0.001). E. Left panels: Epidermal permeability was assessed in E17.5 
MR+/- and MR-/- mice (n=22) by toluidine blue staining. Blue denotes immature epidermis and 
white indicates mature epidermis. Right panels: Histological analysis. H&E indicates 
hematoxylin/eosin staining. Brackets illustrate differences in epidermal thickness, which were 
quantitated in panel F; asterisks indicate altered epidermal differentiation. Bar: 100 m. F-G. 
Morphometric quantitation of epidermal thickness (F) and immunohistochemistry (G). 
Percentage of K5-, K10-, and loricrin (LOR)-positive layers is shown in G. Asterisks indicate 
statistically significant differences relative to MR+/- (n= 7 per genotype; * p<0.05, ** p<0.01, 
*** p<0.001). 
 
Fig. 2. Skin architecture of postnatal MR-/- mice, and HSD11B2 expression during skin 
development. A. Hematoxylin/eosin (H&E) staining, immunolocalization of loricrin (LOR), and 
lipid distribution (Nile red staining) were examined in skin sections collected from MR+/- and 
MR-/- mice at P0 and P4. B. Epidermal proliferation was assessed in MR+/- and MR-/- P0 skin by 
in vivo BrdU incorporation. Statistically significant changes among genotypes were detected 
only at P4 (n= 6 per genotype; ** p-value <0.01). C. Hsd11b1 and Hsd11b2 mRNA levels were 
assessed in developing (E16.5, E18.5, P0) and adult mouse skin by RT-QPCR. Asterisks 
indicate statistically significant differences relative to E16.5 (n=3 per age; * p-value < 0.05; ** 
p-value < 0.01). D-E. Immunohistochemistry for HSD11B2 in skin sections from E16.5, E18.5 
and P0 WT mice (n=12), as well as in P0 MR+/+, MR-/- and GR-/- skin (n=12). Bars: 100 m. 
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Supplementary Materials and Methods 
 
Ethics Statement and Animal Experimentation 
All mice were handled in accordance with the current Spanish and European regulations, and 
approved by our institution’s Ethics committee (approval ID for project SAF2011-28115). 
For analysis of MR expression during development, mice were subjected to timed 
matings, and embryo skin samples were obtained by cesarean derivation. At least 3 samples of 
dorsal WT (B6D2 mice, Janvier Labs) skin for each time-point (E15.5, E16.5, E18.5, P0, 5-wk, 
and 8-wk) or MR+/+, MR+/- and MR-/- (P0) were analyzed for RNA and protein expression.  
 MR-/- mice were generated using a strategy based on generalized CRE-mediated 
recombination of MRloxP/loxP mice. This approach relies on the fact that the keratinocyte-specific 
promoter keratin (K)5 is transcriptionally active in murine oocytes. This implies that when a 
female expresses CRE under the control of the K5 promoter, loxP flanked sequences will be 
deleted in all tissues of the offspring, even in littermates that do not inherit the CRE allele (s7). 
This strategy has been successfully used to achieve ubiquitous CRE-mediated recombination 
(s7). Consequently, by intercrosses of K5-Cre+/-//MRloxP/+ females and 0Cre//MRloxP/+ males, 
three different genotypes were obtained: MR+/+, MR+/- and MR-/- mice. MR+/+ and MR+/- mice 
were used as controls as the phenotype of their skin was indistinguishable. 
 
Histological and Immunohistochemical analysis 
Dorsal skin samples from litters of MR+/- and MR-/-mice at E17.5 (n= 22), P0 (n= 33), or P4 (n= 
12) were collected, fixed in 70% ethanol and embedded in paraffin. BrdU incorporation was 
assessed by immunohistochemistry (anti-BrdU, biotest, Roche, Indianapolis, IN) in paraffin-
embedded sections from mice injected with BrdU 1 hr prior to sacrifice (130g/g of body 
weight, Roche). Polyclonal antibodies to K5 (PRB-160P), K10 (PRB-159P), and loricrin (PRB-
145P) were from Covance (Babco, Berkeley, CA). HSD11B2 antibody was from Santa Cruz 
(sc-20176). Secondary biotin-conjugated anti-rabbit or anti-mouse antibodies (Jackson 
ImmunoResearch) were used. At least 4 skin samples of each genotype and age (E16.5, E18.5, 
and P0 WT; and P0 MR+/+, MR-/- and GR-/-) were used for histopathological analysis. 
 For lipid staining, sections (P0 and P4 MR+/- and MR-/- mice, n= 3 per genotype) were 
incubated with 1mg ml-1 Nile Red (Sigma) in phosphate-buffered saline along with 4´-6-
diamidino-2-phenylindole for 5 minutes at room temperature (8). 
Epidermal dye permeability assay was performed with 1% toluidine blue dye (Sigma) as 
described (s14) in at least five individuals of each genotype (MR+/+, MR+/- and MR-/-).  
 
 
Morphometrical analysis and immunohistochemistry quantitation 
Morphometrical analysis and quantitation of immunohistochemical staining was performed 
using the software IMAGE-PRO PLUS 6.0 (Media Cybernetics, Silver Spring, MD, USA). For 
each sample, five microphotographs were taken at 100x magnification following a method of 
semi-randomization, which excluded altered zones. A Leica DM1000 microscope, a Leica EC3 
camera and Leica LAS EZ software (Leica Microsystems, Wetzlar, Germany) were used.  
The epidermal thickness was determined in H&E stained skin sections of MR+/- and 
MR-/- E17.5, P0 and P4 mice (at least n= 6 per genotype). At least 5 images and 10 sections 
were used per sample. For quantitation of K5, K10, and LOR staining (Fig. 1G), we determined 
the percentage of epidermal thickness that was positive for each marker by manually measuring 
the area. For that purpose, 10 semi-randomized measurements of marker-positive epidermis 
were taken in each image. Additionally, for LOR and HSD11B2 staining (Fig. S2B, S3), the 
intensity of each marker was quantitated by selecting the corresponding expression in each 
image, and measuring the mean intensity of pixels within the segmented in the 
microphotograph. Average intensity of expression of each marker was calculated as mean of all 
images and expressed as relative intensity units. 
 
RNA isolation and Quantitative RT-PCR 
RNA was isolated from mouse dorsal epidermis using Trizol (Invitrogen, Molecular Probes, 
Eugene, Oregon) and reverse transcribed using oligo-dT and RevertAid H-minus Reverse 
Transcriptase (Fermentas Inc., Burlington, Canada). Quantitative PCR was conducted using 
specific oligonucleotides and FastStart Universal SYBR Green Master ROX (Roche) in an 
Applied Biosystems 7500 Fast real time PCR system. Data were normalized to Hprt1 
expression. Specific primers used were as follows: 5´- TGCTATGCTTTGCTCCTGATCTG-3´, 
5´-TGTCAGTTGATAAAACCGCTGCC-3´ for Nr3c1; 5´-
GTGGACAGTCCTTTCACTACCG-3´, 5´-TGACACCCAGAAGCCTCATCTC-3´ for Nr3c2; 
5´-CTAATGATGCTGGACCACACC-3´, 5´-AAAGCGTCTGCTCCGTGATGC-3´ for ENac; 
5´-GGAGCCGCACTTATCTGAA-3´, 5´-GACCTGGCAGTCAATACCA-3´ for Hsd11b1; 5´-
CTGCAGATGGATCTGACCAA-3´, 5´-GTCAGCTCAAGTGCACCAAA-3´ for Hsd11b2; 5´-
GAGCAAAGATGAGGCTGAGG-3´, 5´-CCTCCGCATCAGAAATCAAT-3´ for Krt77; 5´-
TGGTACTCAAGGCCGAGA-3´, 5´-TTTGTCCTGATGACTGCTGAAGAC-3´ for Sprr2d;  
and 5´-TCAGTCAACGGGGGACATAAA-3´, 5´-GGGGCTGTACTGCTTAACCAG 
-3´ for Hprt1.  
 
Immunoblotting 
Preparation of whole cell extracts and immunoblotting were performed as described (7). 
Polyclonal antibody against MR was from Abcam (ab64457; Bristol, UK) and anti-actin was 
from Sigma (A2066). Secondary peroxidase-conjugated anti-rabbit antibody (Amersham) was 
used. 
 
Supplementary Figures 
Supplementary Fig. 1. Relative mRNA levels of Nr3c1, Krt77, and Sprr2d in embryonic 
(E15.5-E18.5) and newborn (P0) mouse skin. Statistically significant differences relative to 
E15.5 are indicated (n= 4 per age; * p<0.05, ** p<0.01, *** p<0.001). 
Supplementary Fig. 2. Quantitation of epidermal thickness (A) and loricrin immunostaining (B) 
in MR+/- and MR-/- P0 and P4 mice (n= 6 per genotype). The intensity of immunostaining for 
loricrin is expressed as relative intensity units. No statistically significant changes were found. 
Supplementary Fig. 3. Quantitation of epidermal HSD11B2 immunostaining A. Comparison 
between embryonic (E16.5, E18.5) and newborn (P0) epidermis (n= 4 per age; * p<0.05). B. 
Epidermal staining intensity in P0 MR+/+, MR-/-, and GR-/- mice P0 (n= 4 per genotype; *** 
p<0.001). Data are expressed as relative intensity units. 
Supplementary Fig. 4. Relative mRNA levels of the -subunit of the amiloride-sensitive 
epithelial Na channel (ENaC/Scnn1a) and Nr3c1 in MR-/- vs MR+/+ P0 skin (n= 5 per 
genotype).  
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